Tower Research Capital LLC (Trc) Kronos Bio, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,201 shares of KRON stock, worth $1,914. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,201
Previous 4,123
46.62%
Holding current value
$1,914
Previous $4,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding KRON
# of Institutions
58Shares Held
19.6MCall Options Held
10KPut Options Held
100-
Vida Ventures Advisors, LLC2.77MShares$2.41 Million3.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$1.67 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.72MShares$1.49 Million0.0% of portfolio
-
Alphabet Inc. Mountain View, CA1.44MShares$1.25 Million0.1% of portfolio
-
Acadian Asset Management LLC Boston, MA1.3MShares$1.13 Million0.0% of portfolio
About Kronos Bio, Inc.
- Ticker KRON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,769,100
- Market Cap $49.4M
- Description
- Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...